Gapping down
News:
- SNDX -10.1% (Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia)
- ARCH -8.6% (provides Q3 update; revises FY23 outlook)
- EGO -2.2% (reports Q3 production; provides project update on Skouries)
- ARR -2.1% (announces effectiveness of one-for-five reverse stock split)
- IMAX -2% (Independent Proxy Advisory Firm Glass Lewis Recommends IMAX China Shareholders Vote "FOR" the Privatization Transaction with IMAX Corporation)
- ORGN -1.6% (appoints Matt Plavan as CFO)
- NSC -1.5% (provided an update Saturday on a technology outage that impacted rail operations; downgraded to Neutral from Buy at BofA Securities)
- TAK -1.1% (announces amendment of compensation recoupment policy)
Analyst comments:
- SEDG -2.8% (downgraded to Equal Weight from Overweight at Barclays)
- BFH -2% (downgraded to Sell from Neutral at Goldman)
- CB -0.8% (downgraded to Neutral from Overweight at JP Morgan)